Paper2168142
Mechanism of action of lomefloxacin.
Piddock LJ and 2 others. Antimicrob Agents Chemother, 1990. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Mechanism of action of lomefloxacin. Papers, record 2168142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2168142
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Infective Agents | Major topic |
| Fluoroquinolones | Major topic |
| Quinolones | Major topic |
| Bacteria | |
| Ciprofloxacin | |
| DNA Topoisomerases, Type II | |
| DNA, Bacterial | |
| DNA, Superhelical | |
| Kinetics | |
| Microbial Sensitivity Tests | |
| Norfloxacin | |
| Rec A Recombinases |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4570289 | Genetic control of DNA initiation in Escherichia coli. | J Mol Biol | 1973 | https://conductscience.org/library/papers/4570289 | PubMed |
| 2 | 6212754 | Quantitative evaluation of recA gene expression in Escherichia coli. | Mol Gen Genet | 1982 | https://conductscience.org/library/papers/6212754 | PubMed |
| 3 | 6086626 | Cloning and simplified purification of Escherichia coli DNA gyrase A and B proteins. | J Biol Chem | 1984 | https://conductscience.org/library/papers/6086626 | PubMed |
| 4 | 3015000 | Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3015000 | PubMed |
| 5 | 2110938 | The accumulation of five quinolone antibacterial agents by Escherichia coli. | J Antimicrob Chemother | 1990 | https://conductscience.org/library/papers/2110938 | PubMed |
| 6 | 3134843 | In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3134843 | PubMed |
| 7 | 3190181 | Pharmacokinetics and tissue penetration of orally administered lomefloxacin. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3190181 | PubMed |
| 8 | 2540707 | Fluorometric assay for fleroxacin uptake by bacterial cells. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2540707 | PubMed |
| 9 | 2555327 | Tryptic fragments of the Escherichia coli DNA gyrase A protein. | J Biol Chem | 1989 | https://conductscience.org/library/papers/2555327 | PubMed |
| 10 | 3476021 | In vitro and in vivo activity of NY-198, a new difluorinated quinolone. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3476021 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32399722 | The anticoccidial activity of the fluoroquinolone lomefloxacin against experimental Eimeria tenella infection in broiler chickens. | Parasitol Res | 2020 | https://conductscience.org/library/papers/32399722 | PubMed |
| 28821547 | Cultivation in Space Flight Produces Minimal Alterations in the Susceptibility of Bacillus subtilis Cells to 72 Different Antibiotics and Growth-Inhibiting Compounds. | Appl Environ Microbiol | 2017 | https://conductscience.org/library/papers/28821547 | PubMed |
| 25787926 | Efficacy and safety of lomefloxacin on bacterial extraocular disease in the horse. | J Vet Med Sci | 2015 | https://conductscience.org/library/papers/25787926 | PubMed |
| 8394795 | Lomefloxacin clinical pharmacokinetics. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8394795 | PubMed |
| 8192436 | New quinolones and gram-positive bacteria. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8192436 | PubMed |
| 1724637 | Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. | Drugs | 1991 | https://conductscience.org/library/papers/1724637 | PubMed |
| 1666499 | Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1666499 | PubMed |
| 1656864 | Inhibition by quinolones of DNA gyrase from Staphylococcus aureus. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1656864 | PubMed |
| 1650698 | Mode of action of the new quinolones: new data. | Eur J Clin Microbiol Infect Dis | 1991 | https://conductscience.org/library/papers/1650698 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2168142
GET https://conductscience.org/api/papers/v1/2168142/authors